Mirae Asset Global Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,680
Closed -$623K 2285
2024
Q1
$623K Sell
22,680
-144,818
-86% -$3.06M ﹤0.01% 1802
2023
Q4
$3.86M Sell
167,498
-56,744
-25% -$1.27M 0.01% 976
2023
Q3
$5.16M Sell
224,242
-8,720
-4% -$222K 0.01% 863
2023
Q2
$6.08M Buy
232,962
+210,282
+927% +$5.55M 0.01% 836
2023
Q1
$626K Buy
22,680
+2,752
+14% +$72.6K ﹤0.01% 1817
2022
Q4
$453K Buy
19,928
+1,687
+9% +$47K ﹤0.01% 1947
2022
Q3
$621K Buy
18,241
+5,610
+44% +$207K ﹤0.01% 1747
2022
Q2
$368K Buy
+12,631
New +$321K ﹤0.01% 1890

Other funds holding PRVA

Mirae Asset Global Investments's PRVA Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 22,680 shares — an estimated $623K sold.

Mirae Asset Global Investments first reported a position in PRVA in Q2 2022 and held it in 8 quarters. The position peaked at $6.08M in Q2 2023. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 22,680 Privia Health shares in Q2 2024, an estimated $623K.
  • Mirae Asset Global Investments first reported a position in Privia Health in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Privia Health position peaked at $6.08M in Q2 2023.
  • 225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.